Corriente Advisors, LLC Bellus Health Inc. Transaction History

Corriente Advisors, LLC

  • $9.53 Million
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$8.88 - $11.15 $1.32 Million - $1.66 Million
-148,666 Closed
0 $0
Q1 2020

May 18, 2020
SELL
$5.77 - $10.85 $411,597 - $773,973
-71,334 Reduced 32.42%
148,666 $1.48 Million
Q4 2019

Feb 14, 2020
BUY
$5.76 - $7.6 $1.27 Million - $1.67 Million
220,000 New
220,000 $1.67 Million

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Corriente Advisors, LLC Portfolio

Follow Corriente Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corriente Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corriente Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email